Lincoln National Corp’s Celgene Corp CELG Stock Holding History

Lincoln National Corp’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-9,627	Closed	-$956K	–	678
2019 Q3	$956K	Sell	9,627 -8	-0.1%	-$760	0.04%	232
2019 Q2	$891K	Sell	9,635 -986	-9%	-$93.6K	0.03%	222
2019 Q1	$1M	Buy	10,621 +593	+6%	+$51.9K	0.04%	199
2018 Q4	$642K	Buy	10,028 +1,396	+16%	+$103K	0.03%	229
2018 Q3	$772K	Buy	8,632 +38	+0.4%	+$3.36K	0.03%	210
2018 Q2	$683K	Buy	8,594 +528	+7%	+$43.8K	0.03%	218
2018 Q1	$719K	Sell	8,066 -7,406	-48%	-$711K	0.03%	210
2017 Q4	$1.61M	Buy	15,472 +8,158	+112%	+$921K	0.05%	178
2017 Q3	$1.07M	Buy	7,314 +3	+0%	+$409	0.04%	129
2017 Q2	$950K	Buy	7,311 +649	+10%	+$79.5K	0.04%	126
2017 Q1	$829K	Sell	6,662 -392	-6%	-$46.9K	0.04%	126
2016 Q4	$816K	Sell	7,054 -7,299	-51%	-$813K	0.04%	138
2016 Q3	$1.5M	Buy	14,353 +81	+0.6%	+$8.77K	0.08%	91
2016 Q2	$1.41M	Buy	14,272 +293	+2%	+$30.3K	0.08%	92
2016 Q1	$1.4M	Sell	13,979 -14,187	-50%	-$1.46M	0.1%	81
2015 Q4	$3.07M	Buy	28,166 +907	+3%	+$105K	0.24%	32
2015 Q3	$3.17M	Buy	27,259 +198	+0.7%	+$24.6K	0.24%	31
2015 Q2	$3.66M	Buy	27,061 +553	+2%	+$63.2K	0.27%	30
2015 Q1	$3.06M	Buy	26,508 +305	+1%	+$36.4K	0.25%	34
2014 Q4	$2.93M	Sell	26,203 -662	-2%	-$69.8K	0.26%	32
2014 Q3	$2.55M	Buy	26,865 +854	+3%	+$77.1K	0.24%	34
2014 Q2	$2.23M	Buy	26,011 +491	+2%	+$37.3K	0.23%	34
2014 Q1	$1.78M	Buy	25,520 +140	+0.6%	+$11.1K	0.25%	36
2013 Q4	$2.14M	Buy	+25,380	New	+$2.01M	0.32%	30

Other funds holding CELG

Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return

HCM

Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

WCG

Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

Lincoln National Corp's CELG Position: Q4 2019 in Review

Lincoln National Corp sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 9,627 shares — an estimated $956K sold.

Lincoln National Corp first reported a position in CELG in Q4 2013 and held it in 24 quarters. The position peaked at $3.66M in Q2 2015. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

Lincoln National Corp reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
Lincoln National Corp sold 9,627 Celgene Corp shares in Q4 2019, an estimated $956K.
Lincoln National Corp first reported a position in Celgene Corp in Q4 2013 and held it in 24 quarters.
Lincoln National Corp's Celgene Corp position peaked at $3.66M in Q2 2015.
4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Lincoln National Corp's 13F filing for Q4 2019, filed 7 Feb 2020.